CatalYm
CatalYm is a Martinsried and San Francisco biopharmaceutical company founded in 2016 that develops visugromab, a GDF-15-neutralizing antibody in late-stage studies to overcome cancer-treatment resistance and cachexia in solid-tumor patients.
Key facts
| Also Known As | CataIYm |
|---|---|
| Company Operating Status | Active |
Open roles at CatalYm
Land a role at CatalYm
publicOpen roles & company overview
Every live role, the locations CatalYm hires across, and the company facts — all above.
membersAlerts & tailored applications
An email the day CatalYm posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.
Get startedEmail & phone for CatalYm are shown to signed-in members. Sign in →